The U.S. Food and Drug Administration (FDA) has released a congressionally mandated report on the safety of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products. This announcement comes under the framework of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) and identifies a critical lack of data needed to assess the safety of PFAS in these widely used consumer products. As of January 12, 2026, the FDA emphasized the need for further research to address these gaps.
PFAS are a group of synthetic chemicals commonly used in various industries, including cosmetics, due to their water- and oil-resistant properties. However, emerging questions about their potential health implications and environmental impact have brought their safety under scrutiny.
In this article
- What changed?
- What are PFAS, and why are they used in cosmetics?
- What are the outlined data gaps?
- Who is affected by this report?
- FAQ
- Conclusion
- Disclaimer
- Official announcement link
What changed?
Under MoCRA’s directive, the FDA conducted a detailed evaluation of PFAS usage within cosmetics. The newly released report does not conclusively determine PFAS safety due to insufficient data. This marks a pivotal acknowledgment by the FDA, highlighting an urgent need for additional research to ensure consumer safety and compliance with regulatory standards.
What are PFAS, and why are they used in cosmetics?
PFAS are a class of over 12,000 chemicals known for their durability and resistance to heat, water, and oil. These properties make them highly desirable for cosmetics, where they serve to improve product performance—such as enhancing the spreadability, durability, and water-resistance of makeup, lotions, and sprays.
However, PFAS have also been linked to environmental persistence and potential health risks. Exposure to certain PFAS has been associated with adverse health outcomes, although the data remains inconclusive in many areas.
What are the outlined data gaps?
The FDA’s report identifies several critical data limitations:
- Lack of exposure data: There is insufficient information about the levels and types of PFAS present in cosmetics.
- Toxicity studies: Many PFAS lack comprehensive evaluations of their potential human health impacts, particularly with prolonged or high-level exposure.
- Environmental impact: The report also highlights gaps in understanding how PFAS used in cosmetics contribute to long-term environmental burden.
These gaps limit the ability to make conclusive judgments about the safety of PFAS in cosmetics and emphasize the pressing need for coordinated research efforts.
Who is affected by this report?
The release of this report has implications for multiple stakeholders:
- Cosmetic manufacturers: Companies must address these uncertainties and prepare for potential regulatory or policy changes.
- Quality and compliance teams: The report signals that heightened monitoring and reformulation efforts might be needed.
- Clinical and public health experts: Researchers are encouraged to conduct studies to fill the knowledge gaps about PFAS toxicology and exposure.
Consumers may also wish to stay informed about PFAS-related developments, particularly if they aim to minimize exposure to potentially harmful chemicals.
FAQ
- What are PFAS? PFAS are synthetic chemicals used for their durability and resistance properties but are often scrutinized for environmental and health risks.
- How are PFAS used in cosmetics? PFAS provide enhanced performance qualities such as water resistance and long-lasting wear in cosmetic products.
- What actions might follow this FDA announcement? Increased research, potential regulatory changes, and possible reformulations of cosmetic products are expected.
Conclusion
The FDA’s findings on the safety of PFAS in cosmetic products underscore the urgent need for additional data to guide regulatory decisions and ensure consumer safety. Stakeholders are encouraged to prioritize research and transparency as the FDA continues its evaluation.
Disclaimer
This article is for informational purposes only and does not constitute legal or regulatory advice. Readers should consult appropriate professionals for specific guidance.
Official announcement link
For full information about the announcement, see the link below.